Cushing Triad, also known as the Cushing reflex, is a medical condition characterized by a combination of three signs: hypertension, bradycardia, and an irregular respiratory rate. It is most commonly associated with increased intracranial pressure (ICP) due to a variety of causes, including traumatic brain injury, brain tumors, hydrocephalus, and intracranial hematomas. The triad is named after Harvey Cushing, an American neurosurgeon who first described the condition in 1932. This article provides a comprehensive overview of Cushing Triad, including its diagnosis and treatment.
The diagnosis of Cushing Triad is based on the presence of three clinical signs: hypertension, bradycardia, and an irregular respiratory rate. Hypertension is defined as a systolic blood pressure greater than 150 mmHg and/or a diastolic blood pressure greater than 90 mmHg. Bradycardia is defined as a heart rate less than 60 beats per minute. An irregular respiratory rate is defined as an increase in the respiratory rate of more than 10 breaths per minute or a decrease in the respiratory rate of more than 10 breaths per minute. The diagnosis of Cushing Triad is usually made based on the presence of these three clinical signs. However, in some cases, additional tests may be necessary to confirm the diagnosis. These tests may include computed tomography (CT) or magnetic resonance imaging (MRI) scans of the head, a lumbar puncture to measure the intracranial pressure, and/or an electroencephalogram (EEG) to measure brain activity.
Cushing Triad is most commonly associated with increased intracranial pressure (ICP) due to a variety of causes, including traumatic brain injury, brain tumors, hydrocephalus, and intracranial hematomas. Other causes of Cushing Triad include meningitis, subarachnoid hemorrhage, and intracranial hypertension due to drug toxicity or metabolic disorders.
The treatment of Cushing Triad is aimed at reducing the underlying cause of the increased intracranial pressure. This may include surgery to remove the tumor or hematoma, or to relieve pressure on the brain. Other treatments may include medications to reduce the pressure, such as diuretics, corticosteroids, and osmotic agents. In some cases, treatment may also include the use of a ventriculostomy, which is a procedure in which a small hole is made in the skull to relieve pressure on the brain. Finally, in some cases, treatment may include the use of a shunt, which is a device that is surgically implanted to divert excess cerebrospinal fluid away from the brain.
Cushing Triad is a medical condition characterized by a combination of three signs: hypertension, bradycardia, and an irregular respiratory rate. It is most commonly associated with increased intracranial pressure due to a variety of causes, including traumatic brain injury, brain tumors, hydrocephalus, and intracranial hematomas. The diagnosis of Cushing Triad is based on the presence of these three clinical signs, and additional tests may be necessary to confirm the diagnosis. Treatment of Cushing Triad is aimed at reducing the underlying cause of the increased intracranial pressure, and may include surgery, medications, a ventriculostomy, or a shunt.
1.
Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.
2.
An Intimate Life of Medical Innovation and Charity.
3.
Decoding calcifications in breast cancer: Towards personalized medicine
4.
Could CT scans be fueling a future rise in cancer cases, as a new study suggests?
5.
Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients
1.
All You Need To Know About Cancer Antigen 27-29: Causes, Symptoms & Treatment
2.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
3.
Expanding Oncology Frontiers: Rare Cancers, Breakthroughs, and Precision Medicine Advances
4.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
5.
From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
2.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation